Nirvana Life Sciences Inc. (CSE: NIRV)

Nirvana Life Sciences Balance Sheet

Financials in millions CAD. Fiscal year is May - April.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Jan 31, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Cash & Equivalents	0	0.01	0.04	0.62
Cash & Short-Term Investments	0	0.01	0.04	0.62
Cash Growth	-26.96%	-65.08%	-94.27%	-
Other Receivables	0.02	0.02	0.01	0.01
Receivables	0.02	0.02	0.01	0.11
Prepaid Expenses	0.03	0.04	0.09	0.04
Total Current Assets	0.05	0.07	0.14	0.77
Property, Plant & Equipment	-	-	0.34	0.43
Total Assets	0.21	0.07	0.49	1.2
Accounts Payable	0.16	0.17	0.07	0.01
Accrued Expenses	0.84	0.78	0.57	0.01
Short-Term Debt	0.02	0.06	-	-
Other Current Liabilities	0.01	0.01	0.01	0
Total Current Liabilities	1.03	1.01	0.65	0.02
Total Liabilities	1.03	1.01	0.65	0.02
Common Stock	6.92	6.38	5.98	1.81
Retained Earnings	-8.27	-7.75	-6.26	-0.61
Comprensive Income & Other	0.53	0.43	0.11	-0.01
Total Common Equity	-0.81	-0.94	-0.16	1.18
Minority Interest	-0	-0	0	-
Shareholders' Equity	-0.82	-0.94	-0.16	1.18
Total Liabilities & Equity	0.21	0.07	0.49	1.2
Total Debt	0.02	0.06	-	-
Net Cash (Debt)	-0.02	-0.05	0.04	0.62
Net Cash Growth	-	-	-94.27%	-
Net Cash Per Share	-0.00	-0.00	0.00	0.02
Filing Date Shares Outstanding	48.23	48.23	34.03	39.83
Total Common Shares Outstanding	48.23	34.03	33.02	39.83
Working Capital	-0.98	-0.94	-0.5	0.75
Book Value Per Share	-0.02	-0.03	-0.00	0.03
Tangible Book Value	-0.98	-0.94	-0.16	1.18
Tangible Book Value Per Share	-0.02	-0.03	-0.00	0.03
Machinery	-	-	0.46	0.46

Source: S&P Capital IQ. Standard template. Financial Sources.